Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase
mBio. 2024 Jul 17;15(7):e0108524. doi: 10.1128/mbio.01085-24. Epub 2024 Jun 20.
PMID:
Kevin E Ramos, Nisreen M A Okba, Jessica Tan, Pooja Bandawane, Philip S Meade, Madhumathi Loganathan, Benjamin Francis, Sergey Shulenin, Frederick W Holtsberg, M Javad Aman, Meagan McMahon, Florian Krammer, Jonathan R Lai
Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland
Respiration. 2024;103(9):593-600. doi: 10.1159/000539410. Epub 2024 May 29.
PMID:
Ralf Otto-Knapp, Torsten Bauer, Folke Brinkmann, Cornelia Feiterna-Sperling, Inna Friesen, Hilte Geerdes-Fenge, Pia Hartmann, Brit Häcker, Jan Heyckendorf, Martin Kuhns, Christoph Lange, Florian P Maurer, Albert Nienhaus, Martin Priwitzer, Elvira Richter, Helmut J F Salzer, Otto D Schoch, Nicolas Schönfeld, Tom Schaberg
Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City
J Virol. 2024 Jun 13;98(6):e0062624. doi: 10.1128/jvi.00626-24. Epub 2024 May 15.
PMID:
Philip S Meade, Pooja Bandawane, Kaitlyn Bushfield, Irene Hoxie, Karla R Azcona, Daneidy Burgos, Sadia Choudhury, Adama Diaby, Mariama Diallo, Kailani Gaynor, Aaron Huang, Kadiatou Kante, Shehryar N Khan, William Kim, Paul Kehinde Ajayi, Ericka Roubidoux, Sasha Nelson, Rita McMahon, Randy A Albrecht, Florian Krammer, Christine Marizzi
Humoral Correlates of Protection Against Influenza A/H3N2 Virus Infection
J Infect Dis. 2024 Dec 16;230(6):1319-1328. doi: 10.1093/infdis/jiae258.
PMID:
Gregory Hoy, Daniel Stadlbauer, Angel Balmaseda, Guillermina Kuan, Roger López, Juan Manuel Carreno Quiroz, Sergio Ojeda, Nery Sánchez, Temima Yellin, Miguel Plazaola, Aaron Frutos, Florian Krammer, Aubree Gordon
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality
J Clin Invest. 2024 May 1;134(9):e176640. doi: 10.1172/JCI176640.
PMID:
Jeremy P Gygi, Cole Maguire, Ravi K Patel, Pramod Shinde, Anna Konstorum, Casey P Shannon, Leqi Xu, Annmarie Hoch, Naresh Doni Jayavelu, Elias K Haddad, IMPACC Network, Elaine F Reed, Monica Kraft, Grace A McComsey, Jordan P Metcalf, Al Ozonoff, Denise Esserman, Charles B Cairns, Nadine Rouphael, Steven E Bosinger, Seunghee Kim-Schulze, Florian Krammer, Lindsey B Rosen, Harm van Bakel, Michael Wilson, Walter L Eckalbar, Holden T Maecker, Charles R Langelier, Hanno Steen, Matthew C Altman
Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City
bioRxiv [Preprint]. 2024 Apr 4:2024.04.04.588061. doi: 10.1101/2024.04.04.588061.
PMID:
Philip S Meade, Pooja Bandawane, Kaitlyn Bushfield, Irene Hoxie, Karla R Azcona, Daneidy Burgos, Sadia Choudhury, Adama Diaby, Mariama Diallo, Kailani Gaynor, Aaron Huang, Kadiatou Kante, Shehryar N Khan, William Kim, Paul Kehinde Ajayi, Ericka Roubidoux, Sasha Nelson, Rita McMahon, Randy A Albrecht, Florian Krammer, Christine Marizzi
Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City
bioRxiv [Preprint]. 2024 Apr 4:2024.04.04.588061. doi: 10.1101/2024.04.04.588061.
PMID:
Philip S Meade, Pooja Bandawane, Kaitlyn Bushfield, Irene Hoxie, Karla R Azcona, Daneidy Burgos, Sadia Choudhury, Adama Diaby, Mariama Diallo, Kailani Gaynor, Aaron Huang, Kadiatou Kante, Shehryar N Khan, William Kim, Paul Kehinde Ajayi, Ericka Roubidoux, Sasha Nelson, Rita McMahon, Randy A Albrecht, Florian Krammer, Christine Marizzi
An ELISA-Based Method to Measure Mucosal Antibody Responses Against SARS-CoV-2 in Human Saliva
Curr Protoc. 2024 Apr;4(4):e1024. doi: 10.1002/cpz1.1024.
PMID:
Disha Bhavsar, Kaori Sano, Gagandeep Singh, Florian Krammer
Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023
Vaccines (Basel). 2024 Mar 8;12(3):284. doi: 10.3390/vaccines12030284.
PMID:
Anita Siller, Lisa Seekircher, Manfred Astl, Lena Tschiderer, Gregor A Wachter, Julia Penz, Bernhard Pfeifer, Andreas Huber, Manfred Gaber, Harald Schennach, Peter Willeit
SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 or XBB.1.5
Cell Rep Med. 2024 Mar 19;5(3):101474. doi: 10.1016/j.xcrm.2024.101474.
PMID:
Anass Abbad, Temima Yellin, Gagandeep Singh, Miriam Fried, Ariel Raskin, Johnstone Tcheou, Brian Monahan, Charles Gleason, PARIS Study Group, Viviana Simon, Juan Manuel Carreño, Florian Krammer